212 related articles for article (PubMed ID: 2182719)
1. Two groups of bullous pemphigoid antigens are identified by affinity-purified antibodies.
Meyer LJ; Taylor TB; Kadunce DP; Zone JJ
J Invest Dermatol; 1990 May; 94(5):611-6. PubMed ID: 2182719
[TBL] [Abstract][Full Text] [Related]
2. Identification of the cutaneous basement membrane zone antigen and isolation of antibody in linear immunoglobulin A bullous dermatosis.
Zone JJ; Taylor TB; Kadunce DP; Meyer LJ
J Clin Invest; 1990 Mar; 85(3):812-20. PubMed ID: 2107211
[TBL] [Abstract][Full Text] [Related]
3. Identification of a 160-kD molecule as a component of the basement membrane zone and as a minor bullous pemphigoid antigen.
Zhu XJ; Niimi Y; Bystryn JC
J Invest Dermatol; 1990 Jun; 94(6):817-21. PubMed ID: 1693941
[TBL] [Abstract][Full Text] [Related]
4. Identification of a basement membrane zone antigen reactive with circulating IgA antibody in ocular cicatricial pemphigoid.
Smith EP; Taylor TB; Meyer LJ; Zone JJ
J Invest Dermatol; 1993 Oct; 101(4):619-23. PubMed ID: 8409534
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel basement membrane antigen (p84) defined by sera with antibodies to both the epidermal and dermal side of split skin.
Gao SQ; Bystryn JC
J Invest Dermatol; 1994 Feb; 102(2):236-40. PubMed ID: 8106753
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneous bullous pemphigoid antibodies: detection and characterization by immunoblotting when absent by indirect immunofluorescence.
Bernard P; Didierjean L; Denis F; Saurat JH; Bonnetblanc JM
J Invest Dermatol; 1989 Feb; 92(2):171-4. PubMed ID: 2645366
[TBL] [Abstract][Full Text] [Related]
7. Identification of basement membrane zone antigens defined by antibodies that react to both the epidermal and dermal side of 1 M sodium chloride split skin.
Niimi Y; Zhu ZX; Bystryn JC
J Invest Dermatol; 1991 Aug; 97(2):312-7. PubMed ID: 1712821
[TBL] [Abstract][Full Text] [Related]
8. Identification and partial characterization of pemphigoid antigen extracted from normal human skin.
Stanley JR; Woodley DT; Katz SI
J Invest Dermatol; 1984 Jan; 82(1):108-11. PubMed ID: 6361166
[TBL] [Abstract][Full Text] [Related]
9. Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting.
Labib RS; Anhalt GJ; Patel HP; Mutasim DF; Diaz LA
J Immunol; 1986 Feb; 136(4):1231-5. PubMed ID: 2418109
[TBL] [Abstract][Full Text] [Related]
10. A 230-kD basic protein is the major bullous pemphigoid antigen.
Mueller S; Klaus-Kovtun V; Stanley JR
J Invest Dermatol; 1989 Jan; 92(1):33-8. PubMed ID: 2462597
[TBL] [Abstract][Full Text] [Related]
11. IgA antibodies in chronic bullous disease of childhood react with 97 kDa basement membrane zone protein.
Zone JJ; Taylor TB; Kadunce DP; Chorzelski TP; Schachner LA; Huff JC; Meyer LJ; Petersen MJ
J Invest Dermatol; 1996 Jun; 106(6):1277-80. PubMed ID: 8752670
[TBL] [Abstract][Full Text] [Related]
12. Antigen specificities of antibasement membrane zone antibodies: immunofluorescence and Western immunoblotting studies.
Muramatsu T; Shirai T; Iida T; Yamashina Y; Sakamoto K
Arch Dermatol Res; 1988; 280(7):411-5. PubMed ID: 2462854
[TBL] [Abstract][Full Text] [Related]
13. Studies of the relationship of the 230-kD and 180-kD bullous pemphigoid antigens.
Robledo MA; Kim SC; Korman NJ; Stanley JR; Labib RS; Futamura S; Anhalt GJ
J Invest Dermatol; 1990 Jun; 94(6):793-7. PubMed ID: 2192002
[TBL] [Abstract][Full Text] [Related]
14. Bullous pemphigoid sera that contain antibodies to BPAg2 also contain antibodies to LABD97 that recognize epitopes distal to the NC16A domain.
Egan CA; Taylor TB; Meyer LJ; Petersen MJ; Zone JJ
J Invest Dermatol; 1999 Feb; 112(2):148-52. PubMed ID: 9989788
[TBL] [Abstract][Full Text] [Related]
15. A case of unique subepidermal blistering disease with autoantibodies against a novel dermal 200-kD antigen.
Kawahara Y; Matsuo Y; Hashimoto T; Nishikawa T
Dermatology; 1998; 196(2):213-6. PubMed ID: 9568410
[TBL] [Abstract][Full Text] [Related]
16. [Molecular heterogeneity of the bullous pemphigoid antigen as detected by immunoblotting].
Izumi H; Hosokawa H
Nihon Hifuka Gakkai Zasshi; 1989 Jul; 99(8):871-5. PubMed ID: 2685419
[TBL] [Abstract][Full Text] [Related]
17. Reactivity of autoantibodies from patients with defined subepidermal bullous diseases against 1 mol/L salt-split skin. Specificity, sensitivity, and practical considerations.
Lazarova Z; Yancey KB
J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):398-403. PubMed ID: 8784276
[TBL] [Abstract][Full Text] [Related]
18. [Use of the immunoblotting technic for the study of antibodies present in the serum of patients with bullous pemphigoid].
Reano A; Thivolet J; Staquet MJ; Fargier MC
Ann Dermatol Venereol; 1988; 115(1):11-8. PubMed ID: 2453132
[TBL] [Abstract][Full Text] [Related]
19. Production of human monoclonal anti-basement membrane zone (BMZ) antibodies from a patient with bullous pemphigoid (BP) by Epstein-Barr virus transformation. Analyses of the heterogeneity of anti-BMZ antibodies in BP sera using them.
Sugi T; Hashimoto T; Hibi T; Nishikawa T
J Clin Invest; 1989 Oct; 84(4):1050-5. PubMed ID: 2551921
[TBL] [Abstract][Full Text] [Related]
20. Studies of cicatricial pemphigoid autoantibodies using direct immunoelectron microscopy and immunoblot analysis.
Bernard P; Prost C; Lecerf V; Intrator L; Combemale P; Bedane C; Roujeau JC; Revuz J; Bonnetblanc JM; Dubertret L
J Invest Dermatol; 1990 May; 94(5):630-5. PubMed ID: 2182720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
